Oliver Flint

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Wei Meng, Bruce A. Ellsworth, Alexandra A. Nirschl et al. · Journal of Medicinal Chemistry · 2008 · 612 citations · Full text

Metabolic Syndrome, Diabetes Management, Biochemistry +10

An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells

Oliver Flint, T.C. Orton · Toxicology and Applied Pharmacology · 1984 · 221 citations

Embryo Culture, Developmental Biology, Morphogenesis +10

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically

Mustafa A. Noor, Oliver Flint, Jen‐Fue Maa et al. · AIDS · 2006 · 152 citations

Inhibition of Cholesterol Synthesis by Squalene Synthase Inhibitors Does Not Induce Myotoxicityin Vitro

Oliver Flint, Barbara A. Masters, Richard E. Gregg et al. · Toxicology and Applied Pharmacology · 1997 · 134 citations

Oxysterol, Biochemistry, Medicine +8

In Vitro Myotoxicity of the 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors, Pravastatin, Lovastatin, and Simvastatin, Using Neonatal Rat Skeletal Myocytes

Barbara A. Masters, Marshall J. Palmoski, Oliver Flint et al. · Toxicology and Applied Pharmacology · 1995 · 132 citations

Vitro Myotoxicity, Biochemistry, Medicine +8